[HTML][HTML] Prevention of Morbidity in Sickle Cell Disease (POMS2a)—overnight auto-adjusting continuous positive airway pressure compared with nocturnal oxygen …

J Howard, SA Lee, B Inusa, MYE Cheng, C Bavenjit… - Trials, 2019 - Springer
Abstract Design This randomised crossover trial compared nocturnal auto-adjusting
continuous positive airway pressure (APAP) and nocturnal oxygen therapy (NOT) in adults …

Prevention of Morbidity in Sickle Cell Disease (POMS2a)-overnight auto-adjusting continuous positive airway pressure compared with nocturnal oxygen therapy: a …

J Howard, SA Lee, B Inusa, MYE Cheng, C Bavenjit… - Trials, 2019 - kclpure.kcl.ac.uk
DESIGN: This randomised crossover trial compared nocturnal auto-adjusting continuous
positive airway pressure (APAP) and nocturnal oxygen therapy (NOT) in adults and children …

Prevention of Morbidity in Sickle Cell Disease (POMS2a)-overnight auto-adjusting continuous positive airway pressure compared with nocturnal oxygen therapy: a …

J Howard, SA Lee, B Inusa, MYE Cheng, C Bavenjit… - Trials, 2019 - europepmc.org
Design This randomised crossover trial compared nocturnal auto-adjusting continuous
positive airway pressure (APAP) and nocturnal oxygen therapy (NOT) in adults and children …

Prevention of Morbidity in Sickle Cell Disease (POMS2a)-overnight auto-adjusting continuous positive airway pressure compared with nocturnal oxygen therapy: a …

J Howard, SA Lee, B Inusa, MYE Cheng, C Bavenjit… - Trials, 2019 - eprints.soton.ac.uk
DESIGN: This randomised crossover trial compared nocturnal auto-adjusting continuous
positive airway pressure (APAP) and nocturnal oxygen therapy (NOT) in adults and children …

[HTML][HTML] Prevention of Morbidity in Sickle Cell Disease (POMS2a)—overnight auto-adjusting continuous positive airway pressure compared with nocturnal oxygen …

J Howard, SA Lee, B Inusa, MYE Cheng, C Bavenjit… - Trials, 2019 - ncbi.nlm.nih.gov
Design This randomised crossover trial compared nocturnal auto-adjusting continuous
positive airway pressure (APAP) and nocturnal oxygen therapy (NOT) in adults and children …

Prevention of Morbidity in Sickle Cell Disease (POMS2a)-overnight auto-adjusting continuous positive airway pressure compared with nocturnal oxygen therapy: a …

J Howard, SA Lee, B Inusa, MYE Cheng, C Bavenjit… - 2019 - pubmed.ncbi.nlm.nih.gov
Design This randomised crossover trial compared nocturnal auto-adjusting continuous
positive airway pressure (APAP) and nocturnal oxygen therapy (NOT) in adults and children …

Prevention of Morbidity in Sickle Cell Disease (POMS2a)-overnight auto-adjusting continuous positive airway pressure compared with nocturnal oxygen therapy: a …

J Howard, SA Lee, B Inusa, MYE Cheng… - Trials, 2019 - researchonline.lshtm.ac.uk
DESIGN: This randomised crossover trial compared nocturnal auto-adjusting continuous
positive airway pressure (APAP) and nocturnal oxygen therapy (NOT) in adults and children …

Prevention of Morbidity in Sickle Cell Disease (POMS2a)—overnight auto-adjusting continuous positive airway pressure compared with nocturnal oxygen therapy: a …

J Howard, SA Lee, B Inusa, MYE Cheng, C Bavenjit… - Trials, 2019 - search.proquest.com
Design This randomised crossover trial compared nocturnal auto-adjusting continuous
positive airway pressure (APAP) and nocturnal oxygen therapy (NOT) in adults and children …

[HTML][HTML] Prevention of Morbidity in Sickle Cell Disease (POMS2a)—overnight auto-adjusting continuous positive airway pressure compared with nocturnal oxygen …

J Howard, SA Lee, B Inusa, MYE Cheng… - …, 2019 - trialsjournal.biomedcentral.com
This randomised crossover trial compared nocturnal auto-adjusting continuous positive
airway pressure (APAP) and nocturnal oxygen therapy (NOT) in adults and children with …

Prevention of Morbidity in Sickle Cell Disease (POMS2a)--overnight auto-adjusting continuous positive airway pressure compared with nocturnal oxygen therapy: a …

J Howard, SA Lee, B Inusa, MYE Cheng, C Bavenjit… - Trials, 2019 - go.gale.com
Design This randomised crossover trial compared nocturnal auto-adjusting continuous
positive airway pressure (APAP) and nocturnal oxygen therapy (NOT) in adults and children …